Evaluation of Reporting of Road Traffic Accidents With Drugs Responsible for Cognitive Side Effects (ERoADS) — ERoADS

Accident, Traffic Clinical Trial

Official title:
Evaluation of Reporting of Road Traffic Accidents With Drugs Responsible for Cognitive and Psychomotor Side Effects (ERoADS)

Status Recruiting

Clinical Trial Summary

Drugs responsible for cognitive and psychomotor side effects may lead to impaired driving skills and road traffic accidents. This study investigates reports of road traffic accident for different class of drugs responsible for cognitive and psychomotor sides effects (pyschotropic agents, neurotropic agents, antineoplasic agents) in the World Health Organization's (WHO) global database of individual safety case reports (VigiBase).

Clinical Trial Description

Some medications are responsible of a wide range of cognitive and psychomotor side effects that may make it unsafe to drive and lead to risks of road accidents .The investigators use VigiBase, the World Health Organization (WHO) database of individual safety case reports, to identify cases of road traffic accidents following treatment with different class of drugs responsible for pyschomotor sides effects. ;

Study Design

Related Conditions & MeSH terms

Accident, Traffic

Clinical Trial Details

NCT number	NCT04480996
Study type	Observational
Source	University Hospital, Caen
Contact	Véronique Lelong-Boulouard, PhD, PharmD
Phone	+33231064670
Email	lelongboulouard-v@chu-caen.fr
Status	Recruiting
Phase
Start date	March 1, 2020
Completion date	June 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06413927` - Driver Education Research Study	N/A
Withdrawn	`NCT03555968` - Effects of THC and Alcohol on Driving Performance	Phase 4
Active, not recruiting	`NCT04238247` - Tiny Cargo, Big Deal! An ED-Based Study of Child Passenger Safety Behaviors	N/A
Completed	`NCT04600908` - Incidence of Commuting Accidents Among Non-physician Staff of a Large University Hospital Center From 2012 to 2016